John H. Durham

Nephrology
3031 Saint Matthews Rd
Orangeburg, SC 29118

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: June 25, 2015
Showing 1-1 of 1

Last Updated: 09/26/2026